Prevalence and Incidence of Abetalipoproteinemia
Prevalance of Abetalipoproteinemia:
only about 100 cases of abetalipoproteinemia reported worldwide, Genetics Home Reference website ... see also overview of Abetalipoproteinemia.
Abetalipoproteinemia: Rare Disease
Abetalipoproteinemia is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Abetalipoproteinemia, or a subtype of Abetalipoproteinemia,
affects less than 200,000 people in the US population.
Ophanet, who are a consortium of European partners,
currently defines a condition rare when if affects 1 person per 2,000.
They list Abetalipoproteinemia as a "rare disease".
More information about Abetalipoproteinemia is available from Orphanet
About prevalence and incidence statistics:
The term 'prevalence' of Abetalipoproteinemia usually refers to the estimated population
of people who are managing Abetalipoproteinemia at any given time.
The term 'incidence' of Abetalipoproteinemia refers to the annual diagnosis rate,
or the number of new cases of Abetalipoproteinemia diagnosed each year.
Hence, these two statistics types can differ:
a short-lived disease like flu can have high annual incidence but low prevalence,
but a life-long disease like diabetes has a low annual incidence but high prevalence.
For more information see about prevalence and incidence statistics.